Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2024-2031

Report ID: 954931 | Published Date: Sep 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Plasma Protein
        1.2.3 Fusion Proteins
        1.2.4 Monoclonal Antibodies
        1.2.5 Hormones
        1.2.6 Enzyme
        1.2.7 Coagulation Factors
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Recombinant Therapeutic Antibodies and Proteins Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oncology
        1.3.3 Hematology
        1.3.4 Immunology
        1.3.5 Endocrinology
        1.3.6 Infectious Disease
        1.3.7 Cardiovascular Disease
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Recombinant Therapeutic Antibodies and Proteins Market Perspective (2016-2027)
    2.2 Recombinant Therapeutic Antibodies and Proteins Growth Trends by Regions
        2.2.1 Recombinant Therapeutic Antibodies and Proteins Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Recombinant Therapeutic Antibodies and Proteins Historic Market Share by Regions (2016-2021)
        2.2.3 Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Regions (2022-2027)
    2.3 Recombinant Therapeutic Antibodies and Proteins Industry Dynamic
        2.3.1 Recombinant Therapeutic Antibodies and Proteins Market Trends
        2.3.2 Recombinant Therapeutic Antibodies and Proteins Market Drivers
        2.3.3 Recombinant Therapeutic Antibodies and Proteins Market Challenges
        2.3.4 Recombinant Therapeutic Antibodies and Proteins Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Recombinant Therapeutic Antibodies and Proteins Players by Revenue
        3.1.1 Global Top Recombinant Therapeutic Antibodies and Proteins Players by Revenue (2016-2021)
        3.1.2 Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Players (2016-2021)
    3.2 Global Recombinant Therapeutic Antibodies and Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Recombinant Therapeutic Antibodies and Proteins Revenue
    3.4 Global Recombinant Therapeutic Antibodies and Proteins Market Concentration Ratio
        3.4.1 Global Recombinant Therapeutic Antibodies and Proteins Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Therapeutic Antibodies and Proteins Revenue in 2020
    3.5 Recombinant Therapeutic Antibodies and Proteins Key Players Head office and Area Served
    3.6 Key Players Recombinant Therapeutic Antibodies and Proteins Product Solution and Service
    3.7 Date of Enter into Recombinant Therapeutic Antibodies and Proteins Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Therapeutic Antibodies and Proteins Breakdown Data by Type
    4.1 Global Recombinant Therapeutic Antibodies and Proteins Historic Market Size by Type (2016-2021)
    4.2 Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Type (2022-2027)

5 Recombinant Therapeutic Antibodies and Proteins Breakdown Data by Application
    5.1 Global Recombinant Therapeutic Antibodies and Proteins Historic Market Size by Application (2016-2021)
    5.2 Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size (2016-2027)
    6.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        6.2.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021)
        6.2.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027)
        6.2.3 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2027)
    6.3 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        6.3.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021)
        6.3.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027)
        6.3.3 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2027)
    6.4 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        6.4.1 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021)
        6.4.2 North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size (2016-2027)
    7.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        7.2.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021)
        7.2.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027)
        7.2.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2027)
    7.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        7.3.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021)
        7.3.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027)
        7.3.3 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2027)
    7.4 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        7.4.1 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021)
        7.4.2 Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size (2016-2027)
    8.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        8.2.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2027)
    8.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        8.3.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2027)
    8.4 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region
        8.4.1 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size (2016-2027)
    9.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        9.2.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021)
        9.2.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027)
        9.2.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2027)
    9.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        9.3.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021)
        9.3.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027)
        9.3.3 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2027)
    9.4 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        9.4.1 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021)
        9.4.2 Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size (2016-2027)
    10.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type
        10.2.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2027)
    10.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application
        10.3.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2027)
    10.4 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country
        10.4.1 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Recombinant Therapeutic Antibodies and Proteins Introduction
        11.1.4 Abbott Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Recombinant Therapeutic Antibodies and Proteins Introduction
        11.2.4 Amgen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.2.5 Amgen Recent Development
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Biogen Business Overview
        11.3.3 Biogen Recombinant Therapeutic Antibodies and Proteins Introduction
        11.3.4 Biogen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.3.5 Biogen Recent Development
    11.4 Eli Lilly
        11.4.1 Eli Lilly Company Details
        11.4.2 Eli Lilly Business Overview
        11.4.3 Eli Lilly Recombinant Therapeutic Antibodies and Proteins Introduction
        11.4.4 Eli Lilly Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.4.5 Eli Lilly Recent Development
    11.5 Roche
        11.5.1 Roche Company Details
        11.5.2 Roche Business Overview
        11.5.3 Roche Recombinant Therapeutic Antibodies and Proteins Introduction
        11.5.4 Roche Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.5.5 Roche Recent Development
    11.6 Johnson and Johnson
        11.6.1 Johnson and Johnson Company Details
        11.6.2 Johnson and Johnson Business Overview
        11.6.3 Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Introduction
        11.6.4 Johnson and Johnson Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.6.5 Johnson and Johnson Recent Development
    11.7 Merck
        11.7.1 Merck Company Details
        11.7.2 Merck Business Overview
        11.7.3 Merck Recombinant Therapeutic Antibodies and Proteins Introduction
        11.7.4 Merck Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.7.5 Merck Recent Development
    11.8 Novo Nordisk
        11.8.1 Novo Nordisk Company Details
        11.8.2 Novo Nordisk Business Overview
        11.8.3 Novo Nordisk Recombinant Therapeutic Antibodies and Proteins Introduction
        11.8.4 Novo Nordisk Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.8.5 Novo Nordisk Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Recombinant Therapeutic Antibodies and Proteins Introduction
        11.9.4 Pfizer Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 Sanofi
        11.10.1 Sanofi Company Details
        11.10.2 Sanofi Business Overview
        11.10.3 Sanofi Recombinant Therapeutic Antibodies and Proteins Introduction
        11.10.4 Sanofi Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
        11.10.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Plasma Protein
    Table 3. Key Players of Fusion Proteins
    Table 4. Key Players of Monoclonal Antibodies
    Table 5. Key Players of Hormones
    Table 6. Key Players of Enzyme
    Table 7. Key Players of Coagulation Factors
    Table 8. Key Players of Others
    Table 9. Global Recombinant Therapeutic Antibodies and Proteins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Regions (2016-2021)
    Table 13. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Regions (2022-2027)
    Table 15. Recombinant Therapeutic Antibodies and Proteins Market Trends
    Table 16. Recombinant Therapeutic Antibodies and Proteins Market Drivers
    Table 17. Recombinant Therapeutic Antibodies and Proteins Market Challenges
    Table 18. Recombinant Therapeutic Antibodies and Proteins Market Restraints
    Table 19. Global Recombinant Therapeutic Antibodies and Proteins Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Players (2016-2021)
    Table 21. Global Top Recombinant Therapeutic Antibodies and Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Antibodies and Proteins as of 2020)
    Table 22. Ranking of Global Top Recombinant Therapeutic Antibodies and Proteins Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Recombinant Therapeutic Antibodies and Proteins Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Recombinant Therapeutic Antibodies and Proteins Product Solution and Service
    Table 26. Date of Enter into Recombinant Therapeutic Antibodies and Proteins Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2016-2021)
    Table 30. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Recombinant Therapeutic Antibodies and Proteins Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Application (2016-2021)
    Table 34. Global Recombinant Therapeutic Antibodies and Proteins Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Abbott Company Details
    Table 67. Abbott Business Overview
    Table 68. Abbott Recombinant Therapeutic Antibodies and Proteins Product
    Table 69. Abbott Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 70. Abbott Recent Development
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Recombinant Therapeutic Antibodies and Proteins Product
    Table 74. Amgen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 75. Amgen Recent Development
    Table 76. Biogen Company Details
    Table 77. Biogen Business Overview
    Table 78. Biogen Recombinant Therapeutic Antibodies and Proteins Product
    Table 79. Biogen Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 80. Biogen Recent Development
    Table 81. Eli Lilly Company Details
    Table 82. Eli Lilly Business Overview
    Table 83. Eli Lilly Recombinant Therapeutic Antibodies and Proteins Product
    Table 84. Eli Lilly Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 85. Eli Lilly Recent Development
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Recombinant Therapeutic Antibodies and Proteins Product
    Table 89. Roche Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 90. Roche Recent Development
    Table 91. Johnson and Johnson Company Details
    Table 92. Johnson and Johnson Business Overview
    Table 93. Johnson and Johnson Recombinant Therapeutic Antibodies and Proteins Product
    Table 94. Johnson and Johnson Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 95. Johnson and Johnson Recent Development
    Table 96. Merck Company Details
    Table 97. Merck Business Overview
    Table 98. Merck Recombinant Therapeutic Antibodies and Proteins Product
    Table 99. Merck Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 100. Merck Recent Development
    Table 101. Novo Nordisk Company Details
    Table 102. Novo Nordisk Business Overview
    Table 103. Novo Nordisk Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 104. Novo Nordisk Recent Development
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Recombinant Therapeutic Antibodies and Proteins Product
    Table 108. Pfizer Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 109. Pfizer Recent Development
    Table 110. Sanofi Company Details
    Table 111. Sanofi Business Overview
    Table 112. Sanofi Recombinant Therapeutic Antibodies and Proteins Product
    Table 113. Sanofi Revenue in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021) & (US$ Million)
    Table 114. Sanofi Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Type: 2020 VS 2027
    Figure 2. Plasma Protein Features
    Figure 3. Fusion Proteins Features
    Figure 4. Monoclonal Antibodies Features
    Figure 5. Hormones Features
    Figure 6. Enzyme Features
    Figure 7. Coagulation Factors Features
    Figure 8. Others Features
    Figure 9. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Application: 2020 VS 2027
    Figure 10. Oncology Case Studies
    Figure 11. Hematology Case Studies
    Figure 12. Immunology Case Studies
    Figure 13. Endocrinology Case Studies
    Figure 14. Infectious Disease Case Studies
    Figure 15. Cardiovascular Disease Case Studies
    Figure 16. Others Case Studies
    Figure 17. Recombinant Therapeutic Antibodies and Proteins Report Years Considered
    Figure 18. Global Recombinant Therapeutic Antibodies and Proteins Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Recombinant Therapeutic Antibodies and Proteins Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Regions: 2020 VS 2027
    Figure 21. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Regions (2022-2027)
    Figure 22. Global Recombinant Therapeutic Antibodies and Proteins Market Share by Players in 2020
    Figure 23. Global Top Recombinant Therapeutic Antibodies and Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Therapeutic Antibodies and Proteins as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Recombinant Therapeutic Antibodies and Proteins Revenue in 2020
    Figure 25. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2016-2021)
    Figure 26. Global Recombinant Therapeutic Antibodies and Proteins Revenue Market Share by Type (2022-2027)
    Figure 27. North America Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2016-2027)
    Figure 29. North America Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2016-2027)
    Figure 30. North America Recombinant Therapeutic Antibodies and Proteins Market Share by Country (2016-2027)
    Figure 31. United States Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2016-2027)
    Figure 35. Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2016-2027)
    Figure 36. Europe Recombinant Therapeutic Antibodies and Proteins Market Share by Country (2016-2027)
    Figure 37. Germany Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Recombinant Therapeutic Antibodies and Proteins Market Share by Region (2016-2027)
    Figure 47. China Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2016-2027)
    Figure 55. Latin America Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2016-2027)
    Figure 56. Latin America Recombinant Therapeutic Antibodies and Proteins Market Share by Country (2016-2027)
    Figure 57. Mexico Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Recombinant Therapeutic Antibodies and Proteins Market Share by Country (2016-2027)
    Figure 63. Turkey Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Recombinant Therapeutic Antibodies and Proteins Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. Abbott Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 67. Amgen Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 68. Biogen Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 69. Eli Lilly Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 70. Roche Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 71. Johnson and Johnson Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 72. Merck Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 73. Novo Nordisk Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 74. Pfizer Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 75. Sanofi Revenue Growth Rate in Recombinant Therapeutic Antibodies and Proteins Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Amgen
Biogen
Eli Lilly
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Frequently Asked Questions
Recombinant Therapeutic Antibodies and Proteins report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Therapeutic Antibodies and Proteins report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Therapeutic Antibodies and Proteins report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ampoules Packaging

Ampoules Packaging is a small sealed vial which is used to contain and preserve a sample, usually ... Read More

Anemia Therapeutics

Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blo ... Read More